Effect of Alemtuzumab Infusions on Vital Signs: A Prospective Observational Study in Patients with Relapsing-Remitting Multiple Sclerosis.

Chinea, Angel; Honeycutt, William David; Miller, Tamara; Graves, Donna; Jacobs, Alan; Wu, Junlong; LaGanke, Christopher C

Chinea, Angel; Honeycutt, William David; Miller, Tamara; Graves, Donna; Jacobs, Alan; Wu, Junlong; LaGanke, Christopher C.

Int J MS Care ; 22(2): 53-59, 2020.

Article em En | MEDLINE | ID: mdl-32410899

Palavras-chave

Alemtuzumab; Disease-modifying therapy (DMT); Infusion; Multiple sclerosis (MS); Relapsing-remitting multiple sclerosis (RRMS); Safety

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204363
https://dx.doi.org/10.7224/1537-2073.2018-076

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7204363
https://dx.doi.org/10.7224/1537-2073.2018-076

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article